Filing Details
- Accession Number:
- 0001140361-16-049007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-28 16:14:31
- Reporting Period:
- 2016-01-26
- Filing Date:
- 2016-01-28
- Accepted Time:
- 2016-01-28 16:14:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 926617 | Vermillion Inc. | VRML | In Vitro & In Vivo Diagnostic Substances (2835) | 330595156 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1021412 | W Jack Schuler | C/O Vermillion, Inc. 12117 Bee Caves Rd Bldg 3 Ste 100 Austin TX 78738 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2016-01-26 | 700 | $1.60 | 2,154,896 | No | 4 | P | Indirect | See footnote |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2016-01-27 | 1,750 | $1.59 | 2,156,646 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | 6,673,029 | Direct |
Footnotes
- The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $1.57 to $1.60. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $1.58 to $1.60. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- These shares of common stock are directly owned by the Jack W. Schuler Living Trust. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.
Billionaire Hedge Funds
